ANTONELLI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 5.257
EU - Europa 2.790
AS - Asia 1.426
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 6
Totale 9.497
Nazione #
US - Stati Uniti d'America 5.229
DE - Germania 763
CN - Cina 685
UA - Ucraina 552
PL - Polonia 544
SG - Singapore 304
RU - Federazione Russa 207
HK - Hong Kong 185
IT - Italia 185
FI - Finlandia 178
TR - Turchia 124
GB - Regno Unito 104
IE - Irlanda 97
FR - Francia 76
IN - India 50
BE - Belgio 39
VN - Vietnam 30
CA - Canada 25
IR - Iran 19
CZ - Repubblica Ceca 12
SE - Svezia 11
AU - Australia 10
EU - Europa 8
ID - Indonesia 8
NL - Olanda 5
MY - Malesia 4
KR - Corea 3
MD - Moldavia 3
RO - Romania 3
AR - Argentina 2
BR - Brasile 2
EE - Estonia 2
ES - Italia 2
HU - Ungheria 2
JM - Giamaica 2
JP - Giappone 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
IQ - Iraq 1
KH - Cambogia 1
MX - Messico 1
NP - Nepal 1
OM - Oman 1
PT - Portogallo 1
TH - Thailandia 1
VE - Venezuela 1
Totale 9.497
Città #
Fairfield 780
Woodbridge 577
Warsaw 544
Ashburn 532
Jacksonville 445
Houston 368
Seattle 298
Ann Arbor 294
Cambridge 290
Singapore 255
Wilmington 255
Chandler 244
Princeton 190
Hong Kong 185
Beijing 181
Helsinki 143
New York 117
Istanbul 104
Nanjing 103
Dublin 97
Dearborn 77
Nürnberg 59
Brescia 49
Nanchang 48
Jinan 47
Des Moines 43
Shanghai 42
Shenyang 42
Moscow 41
Brussels 36
Changsha 31
San Diego 31
Dong Ket 28
Hebei 27
Los Angeles 26
San Mateo 24
Jiaxing 22
Monmouth Junction 22
Washington 21
Tianjin 19
Ardabil 17
Falkenstein 17
Toronto 17
Hangzhou 16
Leawood 15
Milan 15
Kunming 14
Lancaster 14
Munich 14
Verona 13
Frankfurt am Main 12
Hefei 12
Zhengzhou 12
Boardman 11
Lanzhou 11
Orange 11
Augusta 10
Brno 10
London 10
Kocaeli 9
Jakarta 8
Norwalk 8
Guangzhou 7
Ningbo 7
Romola 6
San Francisco 6
Sorgues 6
Taiyuan 6
Haikou 5
Prescot 5
Redwood City 5
Rome 5
Bologna 4
Canberra 4
Carmignano 4
Chiswick 4
Indiana 4
Phoenix 4
Taizhou 4
Changchun 3
Fuzhou 3
Hanover 3
Islington 3
Kilburn 3
Melbourne 3
Mumbai 3
North York 3
Putte 3
Solbiate Olona 3
Acton 2
Amsterdam 2
Bussolengo 2
Caravate 2
Castenedolo 2
Columbus 2
Gunzenhausen 2
New Delhi 2
Philadelphia 2
Pisa 2
Riyadh 2
Totale 7.151
Nome #
Patient's adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: Is combination therapy better than monotherapy 259
Laparoscopic and robotic ureteral stenosis repair: a multi-institutional experience with a long-term follow-up 249
Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship Between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma 176
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 169
[ProACT (Adjustable Continence Therapy) implants in case of failure of other techniques for urinary incontinence]. 162
Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years 153
Pros-IT CNR: an Italian prostate cancer monitoring project 152
Biological bases of radical prostatectomy in the management of prostate cancer patients with oligometastatic disease 145
DISCRIMINATION ABILITY OF THE SURFACE-INTERMEDIATE-BASE MARGIN (SIB) SCORE: AN EXTERNAL HISTOPATHOLOGICAL EVALUATION 141
Prognostic factors in a large multi-institutional series of papillary renal cell carcinoma. 135
The R.E.N.A.L. Nephrometric Nomogram Cannot Accurately Predict Malignancy or Aggressiveness of Small Renal Masses Amenable to Partial Nephrectomy. 129
Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma 128
PATHOGENESIS, FEATURES AND PROGNOSIS OF RENAL RELAPSE AFTER PARTIAL NEPHRECTOMY 128
Features of Ipsilateral Renal Recurrences After Partial Nephrectomy: A Proposal of a Pathogenetic Classification 127
Venous tumor thrombus consistency is not predictive of survival in patients with renal cell carcinoma: A retrospective study of 147 patients 126
OUTCOMES OF PREVENTIVE VS DELAYED LIGATION OF DORSAL VASCULAR COMPLEX DURING RARP: PRELIMINARY RESULTS OF A RANDOMIZED TRIAL 126
External histopathological validation of the surface-intermediate-base margin score 124
Serum vitamin D and prostate cancer prognosis: The story continues 123
Comparison of Perioperative Morbidity of Radical Cystectomy with Neobladder Versus Ileal Conduit: A Matched Pair Analysis of 170 Patients 123
MP34-09 IS A DELAY IN THE TIMING OF RADICAL CYSTECTOMY REALLY DETRIMENTAL? A RETROSPECTIVE STUDY ON A SINGLE CENTRE COHORT 123
Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function 120
PROSPECTIVE ANALYSIS OF COMPLICATIONS AND THEIR PREDICTIVE FACTORS AFTER PARTIAL NEPHRECTOMY IN A MULTICENTER COMPARATIVE ITALIAN STUDY (RECORD1) 120
Partial Nephrectomy in Clinical T1b Renal Tumors: Multicenter Comparative Study of Open, Laparoscopic and Robot-assisted Approach (the RECORd Project) 119
[Differences in morbidity of neobladder versus ileal conduit: a matched pair analysis on 134 patients] 118
Surgically-induced hypertension and cardiovascular morbidity following treatment for localized kidney cancer: the impact of nephrons loss 118
Features, risk factors and clinical outcome of "very late" recurrences after surgery for localized renal carcinoma: A retrospective evaluation of a cohort with a minimum of 10 years of follow up 116
A prospective, multicenter evaluation of predictive factors for positive surgical margins after nephron-sparing surgery for renal cell carcinoma: The record1 italian project 116
A snapshot of nephron-sparing surgery in Italy: A prospective, multicenter report on clinical and perioperative outcomes (the RECORd 1 project) 116
Analysis of radical cystectomy and urinary diversion complications with the Clavien classification system in an Italian real life cohort. 114
A SNAPSHOT OF NEPHRON SPARING SURGERY IN ITALY: A PROSPECTIVE, MULTICENTER REPORT ON CLINICAL AND PERIOPERATIVE OUTCOMES (THE RECORD 1 PROJECT) 114
End-Stage Renal Disease After Renal Surgery in Patients with Normal Preoperative Kidney Function: Balancing Surgical Strategy and Individual Disorders at Baseline 114
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory 113
VARIATIONS IN RENAL CORTEX VOLUMES BEFORE AND AFTER PARTIAL NEPHRECTOMY: A PILOT STUDY ON 30 CASES 113
The occurrence of intraoperative complications during partial nephrectomy and their impact on postoperative outcome: results from the RECORd1 project 111
The percentage of core involved by cancer is the best predictor of insignificant prostate cancer, according to an updated definition (tumor volume up to 2.5 cm3): analysis of a cohort of 210 consecutive patients with low-risk disease. 109
TriMatch comparison of the efficacy of FloSeal versus TachoSil versus no hemostatic agents for partial nephrectomy: Results from a large multicenter dataset 109
The Percentage of Core Involved by Cancer Is the Best Predictor of Insignificant Prostate Cancer, According to an Updated Definition (Tumor Volume up to 2.5 cm(3)): Analysis of a Cohort of 210 Consecutive Patients With Low-risk Disease 109
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 109
DISCRIMINATION ABILITY OF TH SURFACE-INTERMEDIATE-BASE MARGIN :(SIB) SCORE: AN EXTERNAL HISTOPATHOLOGICAL EVALUATION 108
NEPHRON-SPARING SURGERY PROTECTS FROM CHRONIC KIDNEY DISEASE RELATIVE TO RADICAL NEPHRECTOMY BUT DOES NOT IMPACT ON OTHER-CAUSES MORTALITY: LONG-TERM (MORE THAN 10 YEARS) SURVIVAL AND FUNCTIONAL OUTCOMES IN PATIENTS WITH A T1A-T1B RENAL MASS 108
Holographic Reconstructions for Preoperative Planning before Partial Nephrectomy: A Head-to-Head Comparison with Standard CT Scan 107
Predicting prostate cancer at rebiopsies in patients with high-grade prostatic intraepithelial neoplasia: a study on 546 patients. 106
NEPHRON SPARING SURGERY DOES NOT DECREASE OTHER-CAUSES MORTALITY RELATIVE TO RADICAL NEPHRECTOMY IN PATIENTS WITH CLINICAL T1A-T1B RENAL MASS: RESULTS FROM A LARGE MULTI-INSTITUTIONAL STUDY 106
A multicentre matched-pair analysis comparing robot-assisted versus open partial nephrectomy. 105
Predictive factors of overall and major postoperative complications after partial nephrectomy: Results from a multicenter prospective study (The RECORd 1 project) 104
Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients 100
PERIOPERATIVE MORBIDITY OF CLAMP VS OFF-CLAMP ROBOTIC PARTIAL NEPHRECTOMY: PRELIMINARY RESULTS FROM A MULTICENTRE RANDOMIZED CLINICAL TRIAL (THE CLOCK STUDY) 100
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 98
RENAL FUNCTION IMPAIRMENT AFTER NEPHRON SPARING SURGERY OR RADICAL NEPHRECTOMY IN PATIENTS WITH CLINICAL T1A-T1B RENAL MASS AND NORMAL PREOPERATIVE GLOMERULAR FILTRATION RATES: RESULTS FROM A LARGE MULTI-INSTITUTIONAL STUDY 95
Surgical treatment of atypical metastasis from renal cell carcinoma (RCC). 95
Simple enucleation versus standard partial nephrectomy for clinical T1 renal masses: Perioperative outcomes based on a matched-pair comparison of 396 patients (RECORd project). 94
Positive surgical margins and early oncological outcomes of robotic versus open radical prostatectomy at a medium case-load institution 94
HOW LONG SHOULD BE EXTENDED FOLLOW UP AFTER SURGERY FOR RENAL CANCER? RETROSPECTIVE ANALYSIS OF A COHORT OF PATIENTS WITH MORE THAN 10 YEARS OF FOLLOW UP 94
Prognostic role of tumour multifocality in renal cell carcinoma. 91
RALP CAN REDUCE THE RATE OF POSITIVE SURGICAL MARGIN: COMPARISON WITH OPEN PROSTATECTOMY IN A MEDIUM VOLUME CENTER 91
Features Associated with Recurrence Beyond 5 Years After Nephrectomy and Nephron-Sparing Surgery for Renal Cell Carcinoma: Development and Internal Validation of a Risk Model (PRELANE score) to Predict Late Recurrence Based on a Large Multicenter Database (CORONA/SATURN Project). 89
HOW LONG SHOULD BE EXTENDED FOLLOW UP AFTER SURGERY FOR RENAL CANCER? RETROSPECTIVE ANALYSIS OF A COHORT OF PATIENTS WITH MORE THAN 10 YEARS OF FOLLOW UP 87
PERIOPERATIVE MORBIDITY OF CLAMP VERSUS OFF-CLAMP ROBOTIC PARTIAL NEPHRECTOMY: PRELIMINARY RESULTS FROM A MULTICENTRE RANDOMIZED CLINICAL TRIAL (THE CLOCK STUDY) 86
Clinical features and prognosis of patients with renal cancer and a second malignancy 86
Transformation of prostate adenocarcinoma into small-cell neuroendocrine cancer under androgen deprivation therapy: Much is achieved but more information is needed 85
WIDESPREAD PIN CAN PREDICT THE DIAGNOSIS OF PROSTATE CANCER AFTER A FIRST NEGATIVE RE-BIOPSY 85
MANAGEMENT AND PROGNOSIS OF POSITIVE SURGICAL MARGINS AFTER RADICAL PROSTATECTOMY: RETROSPECTIVE ANALYSIS OF A CONTEMPORARY COHORT 84
OUTCOMES OF PREVENTIVE VS. DELAYED LIGATION OF DORSAL VASCULAR COMPLEX DURING RARP: A RANDOMIZED TRIAL 84
HOW LONG SHOULD THE FOLLOW-UP BE EXTENDED AFTER SURGERY FOR RENAL CANCER? RETROSPECTIVE ANALYSIS OF A COHORT OF PATIENTS WITH MORE THAN 10 YEARS OF FOLLOW-UP 83
ROBOT-ASSISTED RADICAL PROSTATECTOMY: LEARNING-CURVE AND CONTINENCE RATES 81
END STAGE RENAL DISEASE AFTER SURGERY IN PATIENTS WITH NORMAL PREOPERATIVE KIDNEY FUNCTION: THE EFFECT OF NEPHRON-SPARING SURGERY IN DELAYING THE ONSET OF THE DISEASE 81
IS A DELAY IN THE TIMING OF RADICAL CYSTECTOMY REALLY DETRIMENTAL? A RETROSPECTIVE STUDY 80
Survival and complication rates of metastasectomy in patients with metastatic renal cell carcinoma treated exclusively with targeted therapy: A Combined Population-based Analysis 80
PIV-03 NEPHRON SPARING TECHNIQUES INDEPENDENTLY REDUCE THE RISK OF CARDIOVASCULAR EVENTS AFTER SURGERY IN PATIENTS WITH CLINICAL T1A-T1B RENAL MASS AND NORMAL PREOPERATIVE GLOMERULAR FILTRATION RATES: RESULTS FROM A LARGE MULTI-INSTITUTIONAL STUDY 78
Cardiopulmonary bypass with brain perfusion for renal cell carcinoma with caval thrombosis 78
OUTCOMES OF A PHASE II I RANDOMIZED CONTROLLED TRIAL COMPARING PREVENTIVE VERSUS DELAYED LIGATION OF DORSAL VASCULAR COMPLEX DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY 77
Renal Cancer Follow-up Counterpoint: Europe 76
IMPACT OF GENDER IN NEPHRON-SPARING SURGERY: COMPARISON OF PERIOPERATIVE AND PATHOLOGICAL OUTCOMES FROM THE DEFINITIVE RESULTS OF RECORD1 PROJECT 76
Role of Clinical and Surgical Factors for the Prediction of Immediate, Early and Late Functional Results, and its Relationship with Cardiovascular Outcome after Partial Nephrectomy: Results from the Prospective Multicenter RECORd 1 Project 76
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 71
ROBOT-ASSISTED PARTIAL NEPHRECTOMYAND BILATERAL PYELOLYTHOTOMY OF ECTOPIC PELVIC KIDNEYS 70
PD49-06 THE ADHERENCE TO THE EAU GUIDELINES ON PENILE CANCER TREATMENT COULD INFLUENCE THE SURVIVAL: MULTICENTER, RETROSPECTIVE, EUROPEAN STUDY 69
HEAD-TO-HEAD EXTERNAL VALIDATION OF RENAL, PADUA, ABC SCORES AND C-INDEX IN NEPHRON SPARING SURGERY 67
Neoadjuvant androgen deprivation therapy through intense inhibition of the androgen target: "Midsummer Night's Dream" or "Much Ado About Nothing"? 67
Cytogenetic features, clinical significance and prognostic impact of type 1 and type 2 papillary renal carcinoma. 66
NEPHRON SPARING TECHNIQUES INDEPENDENTLY REDUCE THE RISK OF CARDIOVASCULAR EVENTS AFTER SURGERY IN PATIENTS WITH CLINICAL T1A-T1B RENAL MASS AND NORMAL PREOPERATIVE GLOMERULAR FILTRATION RATES: RESULTS FROM A LARGE MULTI-INSTITUTIONAL STUDY 65
On-clamp versus off-clamp robotic partial nephrectomy: A systematic review and meta-analysis 65
External Validation of the Arterial-Based Complexity Score and First Head-to-Head Comparison With the R.E.N.A.L. and PADUA Scores and C-index 63
CHEST FOLLOW-UP SCHEDULE OF SURGICALLY RESECTED RENAL CELL CARCINOMA SHOULD BE DIFFERENTIATED ACCORDING TO HISTOLOGICAL SUBTYPE 60
Nomogram for predicting the likelihood of postoperative surgical complications in patients treated with partial nephrectomy: a prospective multicentre observational study (the RECORd 2 project) 60
Prognostic role of delay before radical cystectomy: Retrospective analysis of a single-center cohort with 376 patients 60
Tumour contact surface area as a predictor of postoperative complications and renal function in patients undergoing partial nephrectomy for renal tumours 60
PERIOPERATIVE COMPLICATIONS AFTER PARTIAL NEPHRECTOMY FOR COMPLEX (PADUA SCORE >= 10) RENAL TUMORS: A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY (THE RECORD2 PROJECT) 59
THE ADHERENCE TO THE EAU GUIDELINES ON PENILE CANCER TREATMENT COULD INFLUENCE SURVIVAL: MULTICENTER, RETROSPECTIVE, EUROPEAN STUDY 56
POSITIVE SURGICAL MARGINS PREDICT PROGRESSION-FREE SURVIVAL AFTER NEPHRON SPARING SURGERY FOR RENAL CELL CARCINOMA: RESULTS FROM A SINGLE CENTRE COHORT OF ALMOST 500 CASES WITH A MINIMUM FOLLOW_UP OF 5 YEARS 49
Health-related quality of life 24-month after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study 46
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study) 35
Is off-clamp robot-assisted partial nephrectomy beneficial for renal function? Data from the CLOCK trial 35
SURGICAL NOMOGRAM FOR PREDICTING THE LIKELIHOOD OF POSTOPERATIVE SURGICAL COMPLICATIONS IN PATIENTS TREATED WITH PARTIAL NEPHRECTOMY:APROSPECTIVE MULTICENTER OBSERVATIONAL STUDY (THE RECORD 2 PROJECT) 33
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study 32
A data-driven approach to refine predictions of differentiated thyroid cancer outcomes: a prospective multicenter study 30
Contemporary Cytoreductive Nephrectomy Provides Survival Benefit in Clear-cell Metastatic Renal Cell Carcinoma 22
A Prospective, Multicenter Study Examining the Relationship between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis 16
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 14
PET/CT and Conventional Imaging for the Assessment of Neuroendocrine Prostate Cancer: A Systematic Review 13
Totale 9.587
Categoria #
all - tutte 45.331
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.331


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.436 0 0 0 0 0 0 252 280 185 436 134 149
2020/20211.601 48 151 59 203 76 155 64 170 162 216 210 87
2021/2022771 96 95 19 22 14 44 29 50 47 96 56 203
2022/2023688 100 14 37 43 71 182 0 62 98 4 42 35
2023/2024976 51 19 72 100 58 229 24 48 203 26 9 137
2024/2025658 13 14 10 272 179 170 0 0 0 0 0 0
Totale 9.685